Archive

podcasts_lgPodcast

  • Key concerns from the Karolinska Institute
    Pharma IQ is joined by Mark Divers, head of the biobank at the Karolinska Institute in Sweden to discuss some of the prevalent aspects in this growing field, including the importance of international partnerships, the problem with standardizing protocol, and the ongoing questions over ethical considerations. He will be just one of the experts on our speaker panel.

    Unable to listen? Read the full transcript here

presentations_lg Sample of Previous Year's Global Biobanking Presentations


Developing Evidence-Based Biospecimen Quality Indicators: What Constitutes Sample Integrity.
Presentation by: Dr. Jim Vaught, Deputy Director, Office of Biorepositories and Biospecimen Research, National Cancer Institute


Afternoon Keynote Session: Developing And Evolving Established Biobanks.
Presentation by: Tim Peakman, Executive Director, UK Biobank Tech Snapshot Session

articles_lg Articles

articles_lgSponsors resources:

[ Register Now ]